Press Releases

Vanessa Research Proudly Supported Rare Disease Day

Rare Disease Day is observed internationally on the last day of February to raise awareness regarding the 300 million people worldwide who are battling rare diseases. Vanessa Research proudly supported Rare Disease Day for the fourth consecutive year. Unlike years past, in 2021 events were virtual because of the ongoing global COVID-19 pandemic.

Shimmer Launches Pulse+ the First Line Extension for its Verisense® Wearable Sensing Platform for Clinical Trials

Shimmer’s Verisense platform can now measure clinical trial participants’ heart rate, oxygen saturation and emotional responses in addition to their activity and sleep levels.

New personalised therapeutics partner joins Repositive Cancer Model network

Repositive has today announced that Vivan Therapeutics, an innovative personalised therapeutics company, will be the next company to join its global network of cancer model partners. Vivan Therapeutics has unique experience in engineering drosophila ‘avatar’ models for cancer research and development unique experience in engineering drosophila ‘avatar’ models for cancer research and development.

CD Bioparticles Releases Chitosans for Research Use

CD Bioparticles launches a series of chitosans for global research communities to support drug delivery studies.

BOC Sciences Upgrades Organelle Fluorescent Probe Product List

108Labs Launches Colostrupedics™ Whole-Human Infant Formula with Secretory Antibodies

108Labs announces Colostrupedics™ whole-human infant formula, made possible with the discovery of novel secretory antibody biosynthesis. This is the first animal-free infant formula that exclusively comprises cell-cultured human milk molecules derived from human mammary cell agriculture and formulated with broadly-neutralizing human secretory antibodies.

Cytel’s East Bayes® Broadens & Simplifies Access to Complex Bayesian Clinical Trial Designs

Cytel has launched East Bayes®, an enhanced web-based extension of the East® platform that enables adoption of the most computationally intensive Bayesian clinical trial designs – without the need for powerful on-site computers.

Leinco Technologies, Inc. and La Jolla Institute for Immunology announce license agreement to develop novel COVID-19 diagnostic tools

Leinco Technologies, Inc., a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates, has signed a licensing agreement with La Jolla Institute for Immunology (LJI), one of the leading research organizations dedicated to studying the immune system, to develop novel COVID-19 diagnostics tools.

PCR Biosystems launches advanced Bst Polymerase reagents for accelerated DNA and RNA amplification

PCR Biosystems have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification. Without the need for high temperature denaturation or specialised thermocycling equipment, IsoFast™ Bst Polymerase enables faster results and can be used in the field. This makes it ideal for a range of applications including environmental and food pathogen testing and clinical diagnostics – including for qualitative detection of the SARS-CoV-2 nucleic acid.

SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines

SB3000 received grant funding from Danish Innovation Fund for its continuous manufacturing enabling technology for medicine production.

Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO

Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth

PHARMASEAL’s Engility® platform fights off competition to be selected by award-winning US Medical Device company

Healthtech company Raremark® reboots as XperiomeTM to drive increased value for rare disease patients and researchers

World first - biological evidence reveals scalp cooling physically protects hair from chemotherapy

Groundbreaking research announced ahead of World Cancer Day 2021, helps prove that scalp cooling protects hair follicles from chemotherapy drugs. A recent study, part of an innovative hair follicle research project carried out by the Scalp Cooling Research Centre at the University of Huddersfield, demonstrates how scalp cooling works and the mechanism behind its protection of the hair follicle.

Atik Cameras Supports the COVID-19 Fight with Wide Range of Advanced Imaging Solutions for Use with PCR Instruments

Atik Cameras, a specialist designer and manufacturer of advanced scientific imaging solutions, has further expanded its collaboration with leading global Original Equipment Manufacturers (OEMs) of real time Polymerase Chain Reaction (PCR) DNA amplifiers, securing multiple new contracts to supply high-performing cameras for reliable COVID-19 testing.

KCR opens new branch in Sydney, Australia

KCR, the international clinical development solutions provider, today announced the establishment of a new branch in Sydney, Australia. The new location will enhance KCR’s regional coverage and maximize clinical capabilities for clients across the globe.

Alfa Chemistry Materials Offers Battery Materials to Produce Organic and Printed Electronics

Saama Teams with Oracle to Offer Life Sciences Industry AI-Enabled Applications to Accelerate Clinical Trials

Saama and Oracle collaborate to bring game-changing, AI-powered smart applications to the Life Sciences industry to speed clinical development

Quinten spins off 50 data scientists to become a global leader in precision care using artificial intelligence and real-world data science

Quinten, a pioneer in AI-powered decision support solutions, has launched Quinten Health — a global and integrated analytical services and tools development offer.